Neurology® Podcast

1) Restless legs syndrome and 2) evidence-based medicine (part 2). This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Aman Savani interviews Dr. Diego Garcia-Borreguero about his paper on restless legs syndrome. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about fatal gastroenteritis. In the next part of the podcast Dr. Michael Benatar interviews Dr. Mark Conaway for part two on evidence-based medicine relative risk, relative risk reduction, absolute risk reduction, and NNT for our Lesson of the Week. You may also want to check out the other two-part series on evidence-based medicine where Dr. Michael Benatar interviewed Dr. Gary Gronseth for our March 30 and April 6 Lesson of the Week. The participants had nothing to disclose except Dr. Garcia-Borreguero. Dr. Garcia-Borreguero has served on scientific advisory boards for and received sp

1) Embouchure dystonia and 2) progressive myoclonic encephalopathies. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Robert Pascuzzi interviews Dr. Bernhard Haslinger about his paper on embouchure dystonia. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about the corneal reflex in stroke. In the next part of the podcast Dr. Alberto Espay interviews Dr. Berge Minassian for part 2 on progressive myoclonic encephalopathies for our Lesson of the Week. The participants had nothing to disclose except Drs. Haslinger, Pascuzzi and Espay. Dr. Haslinger serves on a scientific board for Merz Pharmaceuticals, LLC; has received funding from travel from Ipsen, Merz Pharmaceuticals, LLC, and Medtronic, Inc.; has received speaker honoraria from Novartis, GlaxoSmithKline, Desitin Pharmaceuticals, GmbH, Ipsen, and Allergan, Inc.; receives research suppo

1) Guillain-Barré syndrome vs. CIDP and 2) progressive myoclonic encephalopathies. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Erik Ensrud interviews Dr. Pieter van Doorn about his paper on Guillain-Barré syndrome. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about Harlequin syndrome. In the next part of the podcast Dr. Alberto Espay interviews Dr. Berge Minassian for part 1 on progressive myoclonic encephalopathies for our Lesson of the Week. The participants had nothing to disclose except Drs. van Doorn and Espay.Dr. van Doorn receives research support from the Prinses Beatrix Fonds, the GBS-CIDP Foundation International and from Baxter biopharmaceutics.Dr. Espay received has personal compensation as a consultant for Boehringer Ingelheim; grant support from Codman; Medtronic, Inc; Allergan, Inc.; and CleveMed, and honoraria from

Frontotemporal dementia and advocacy. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns interviews Dr. Eneida Mioshi about her paper on frontotemporal dementia. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about atypical unilateral severe facial pain in smokers. In the next part of the podcast Dr. Ted Burns interviews Dr. Robert Griggs on advocacy for our Lesson of the Week. The participants had nothing to disclose except Drs. Mioshi, Burns and Griggs.Dr. Mioshi serves on the editorial board of Dementia and Geriatric Cognitive DisordersDr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuromuscular practice (30% effort).Dr. Griggs serves on the editorial advisory board for Current Treatment Options in Neurology and NeuroRX; has received honoraria for lectures or educational activit

Hippocampal removal and evidence-based medicine (part 1). This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ryan Overman interviews Dr. Marla Hamberger about her paper on hippocampal removal. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about the "slurp" test for children with myasthenia gravis. In the next part of the podcast Dr. Michael Benatar interviews Dr. Mark Conaway for part one on evidence-based medicine risk and rate for our Lesson of the Week. The participants had nothing to disclose except Drs. Overman and Hamberger. Dr. Overman serves as Deputy Editor on the Neurology® Resident and Fellow Section editorial team and the Neurology® Podcast Committee. Dr. Hamberger serves on the editorial board of Epilepsy and Behavior and receives research support from the NIH (NINDS R01 NS35140 [PI]). Dr. Overman serves as Deputy Editor on t

Leptomeningeal metastases and acute dizziness. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michelle Mauermann interviews Dr. Lisa DeAngelis about her paper on leptomeningeal metastases. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about hemiballism. In the next part of the podcast Dr. Beau Bruce interviews Dr. David Newman-Toker on acute dizziness for our Lesson of the Week. The participants had nothing to disclose except Dr. DeAngelis.Dr. DeAngelis has served on a scientific advisory board for Genentech, Inc.; serves on the editorial board of Neurology; receives royalties from the publication of The Neurologic Complications of Cancer (Oxford University Press, 2008); and has received research support from the NIH (UO1 CA-105663-01 [Participating Member in the NABTC]).

Safety of t-PA in stroke and Rett syndrome. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Sean Savitz about his paper on safety of t-PA in stroke. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about ophthalmoplegia in herpes zoster ophthalmicus. In the next part of the podcast Dr. Alberto Espay interviews Dr. SakkuBai Naidu for our Lesson of the Week about Rett syndrome. In concluding, there is a brief statement where to find other up-to date patient information and current Patient Page. The participants had nothing to disclose except Drs. Savitz and Espay. Dr. Savitz serves on a scientific advisory board for Grupo Ferrer Internacional S.A.; has received travel expenses and/or honoraria for lectures or educational activities not funded by industry; serves as an Associate Editor of Experimental and Tran

Driving risk in dementia and survey results on sedation for imminently dying. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Russ Swerdlow interviews Dr. Don Iverson about the AAN guidelines update on driving risk in dementia. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about motor movements in brain death. In the next part of the podcast Dr. Ted Burns interviews Dr. Jim Russell for our Lesson of the Week about the AAN Ethics Section survey results on sedation for the imminently dying. The participants had nothing to disclose except Drs. Burns and Russell.Dr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuromuscular practice (30% effort).Dr. Russell serves on the scientific advisory board for the Massachusetts Chapter of the ALS Association; and receives royalties from the publication o

Migraine care and principles of bioethics (part 3). This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jim Gordon interviews Dr. Rachel Nardin about her paper on migraine care in the United States. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about stroke with primary brain tumors. In the next part of the podcast, Dr. Ted Burns interviews Dr Dan Larriviere for our Lesson of the week about principles of bioethics: respect of nonmaleficence. The participants had nothing to disclose except Drs. Gordon, Nardin, Burns and Larriviere.Dr. Gordon has received speaker fees from the University of Washington School of Nursing for two talks.Dr. Nardin has received honoraria for lectures not funded by industry; serves on the editorial board of Muscle & Nerve; and has received royalties from publications in Up-to-date.Dr. Burns receives a stipend

Poliovirus-infected macrophages in thymus and part two on evidence-based medicine. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Renato Bernasconi about his paper on myasthenia gravis. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about a mimic of hemicranias continua. In the next part of the podcast Dr. Michael Benatar interviews Dr. Gary Gronseth for part two on evidence-based medicine for our Lesson of the Week. The participants had nothing to disclose except Drs. Burns and Gronseth.Dr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuromuscular practice (30% effort).Dr. Gronseth serves as an editorial advisory board member of Neurology Now; serves on a speakers bureau for Boehringer Ingelheim; and receives honoraria from Boehringer Ingelheim and the American Ac

Subdiaphragmatic visceral infarction and part one on evidence-based medicine. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Justin Sattin interviews Dr. Pierre Amarenco about his paper on visceral infarction in cardioembolic stroke. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about neuroimaging in paroxysmal hemicranias and SSUNCT syndrome. In the next part of the podcast Dr. Michael Benatar interviews Dr. Gary Gronseth for part one on evidence-based medicine for our Lesson of the Week. The participants had nothing to disclose except Dr. Gronseth.Dr. Gronseth serves as an editorial advisory board member of Neurology Now; serves on a speakers bureau for Boehringer Ingelheim; and receives honoraria from Boehringer Ingelheim and the American Academy of Neurology.

Familial essential tremor and update H1N1 and risk of GBS. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matt Barrett interviews Dr. Giuseppe Nicoletti about his paper on familial essential tremor. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about fibrocartilaginous embolism myelopathy. In the next part of the podcast Dr. Ted Burns interviews Dr. Jim Sejvar for our Lesson of the Week about H1N1 vaccination and risk of GBS an update. The participants had nothing to disclose except Dr. Burns.Dr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuromuscular practice (30% effort).

Non-motor symptoms of Parkinson disease and improving the no-show rate in residents clinic. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeremy Lanford interviews Dr. Theresa Zesiewicz about the AAN guidelines on non-motor symptoms of Parkinson disease. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week. In the next part of the podcast Dr. Alex Menze interviews Dr. Raymond Price for our Lesson of the Week about Resident & Fellow submission on education research. The participants had nothing to disclose except Dr. Zesiewicz.Dr. Zesiewicz has received funding for travel from and served on speakers bureaus for Boehringer Ingelheim and Teva Pharmaceutical Industries Ltd.; and receives research support from Boehringer Ingelheim, Novartis, GlaxoSmithKline, UCLA-RAND, Teva Neuroscience, Pfizer Inc, Allergan, Inc., the National Ataxia Founda

Fibrillar amyloid-beta and Bioethics-beneficence. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Brandy Matthews interviews Dr. Susan Resnick about her paper on cognitive decline is associated with fibrillar amyloid-beta. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about the Eastchester clapping sign. In the next part of the podcast Dr. Ted Burns interviews Dr. Dan Larriviere for our Lesson of the Week about principles of bioethics-beneficence. The participants had nothing to disclose except Drs. Resnick, Matthews, Larriviere, and Burns.Dr. Resnick serves as Action Editor for Brain and Cognition; and received research support from the NIH/NIA Intramural Research Program.Dr. Matthews received honoraria for attending the AAN Annual Meeting in Seattle in 2009; and received research support from Indiana Alzheimer Disease Center, and NIA

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Andrea Pace about his paper on cisplatin neuropathy. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about atrophy in MuSK-antibody positive myasthenia gravis. In the next part of the podcast Dr. Alberto Espay interviews Dr. Joanna Jen for our Lesson of the Week about benign paroxysmal positional vertigo vs. posterior circulation stroke. The participants had nothing to disclose except Drs. Pace, Burns and Espay. Dr. Pace has received speaker honoraria from Schering-Plough Corp. and Italfarmaco.Dr. Burns receives a stipend as Podcast Editor for Neurology®, and performs EMG studies in his neuromuscular practice (30% effort).Dr. Espay received has personal compensation as a consultant for Boehringer Ingelheim; grant support from Codman; Medtronic, Inc; Allergan, Inc.;

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Hans Dieter Katzberg about the AAN guidelines on treatment for muscle cramps. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about coat hanger sing in multiple sclerosis atrophy. In the next part of the podcast Dr. Beau Bruce interviews Dr. Robert Naismith for our Lesson of the Week about natalizumab (Tysabri). The participants had nothing to disclose except Drs. Burns and Katzberg. Dr. Burns receives a stipend as Podcast Editor for Neurology®, performs EMG studies in his neuromuscular practice (30% effort), and received compensation for a presentation on MG-QOL15, given to study investigators of eculizumab in myasthenia gravis.Dr. Katzberg has received funding for travel from the Muscular Dystrophy Association.

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Benjamin Atkinson interviews Dr. Thanh Phan about his paper on hypoxic coma: A meta-analysis. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about distinguishing dystonic tremor from essential tremor. In the next part of the podcast Dr. Julian Bragg interviews Dr. Miguel Hernán for our Lesson of the Week about bias. The participants had nothing to disclosure.

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Brett Kissela interviews Dr. John Ly about his paper on cerebral amyloid angiopathy related hemorrhage. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about psychogenic non-epileptic seizures. In the next part of the podcast, Dr. Ted Burns interviews Dr Dan Larriviere for our Lesson of the week toolbox about principles of bioethics: respect of autonomy. The participants had nothing to disclosure except for Drs. Kissela, Larriviere and Burns.Dr. Kissela served on the scientific advisory board for Allergan, Inc in 2009; served as a consultant for Allergan for 2-day meeting in 2009; received honoraria from CME program and unrestricted educational grants; received research support from the NIH [R01 NS 30678], [N01 NS 081588], [1Ul1 RR026314] and received compensation for reviewing records for

This Podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Quigg interviews Dr. Rainer Surges and Prof. Matthew Walker about their paper on generalized seizures. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about HSV-1 encephalitis and falsely negative PCR. In the next part of the podcast is Dr. Alberto Espay interviews Dr. Curt LaFrance for our Lesson of the week toolbox about psychogenic non-epileptic seizures. The participants had nothing to disclosure except for Prof. Walker, Drs. Surges and Espay. Dr. Surges received research support from Deutsche Forschungsgemeinschaft.Prof. Walker serves on scientific advisory boards for GlaxoSmithKline, Eisai Inc., UCB, and Sierra Neuro; has received travel expenses and honoraria for lectures or educational activities not funded by industry; serves as an Associate Editor of Epilepsia and Therapeutic

1. Brain death, the determination of brain death, and member guidance for brain death accommodation requests: AAN position statement. 2. [What’s Trending]: On tau protein and Alzheimer dementia symptoms. In the first segment, Dr. Jason Crowell talks with Dr. James Russell about his paper on brain death, the determination of brain death, and member guidance for brain death accommodation requests. In the second part of the podcast, Dr. Jeff Burns focuses his interview with Dr. Matthew Brier on tau protein and Alzheimer dementia symptoms.DISCLOSURES: Dr. Jason Crowell reports no disclosures. Dr. James Russell has served on Scientific Advisory Boards for Cytokinetics - Data Monitoring Board PROTOCOL CY 5022 A PHASE 2, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, DOSE- RANGING, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF CK-2127107 IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS). Dr. James Russell received travel funding from 1) Non-profit - Mexican Academy of Neurology - Funded